Time is running out to register for our upcoming, expert-led, one-day symposium on Duchenne Muscular Dystrophy (DMD) on July 11, 2025, in Prague, Czechia. This event is aimed at industry professionals who are either new to working in Duchenne or lack a complete overview.
Symposium Focus
The symposium will delve into several pivotal areas:
- Outcome Measures: Discussing the latest methodologies to assess DMD progression and treatment efficacy.
- Genetic Advancements: Exploring breakthroughs in genetic research that could influence DMD therapies.
- Treatment Advancements: Reviewing new therapeutic approaches and their clinical implications.
- Internationally Recognised Standards of Care: Highlighting best practices in DMD patient management.
Objectives
The event aims to:
- Equip participants with practical insights and tools applicable to their work in DMD.
- Foster a collaborative environment for discussions, idea-sharing, and addressing challenges in the field.
Target Audience
This symposium is ideal for professionals in the pharmaceutical or biotech industries who are either new to the DMD field or seeking to broaden their knowledge. Attendees will have the opportunity to learn from key opinion leaders and gain a comprehensive overview of current DMD research and treatment landscapes.
You can view the programme for the event here: DMD Industry Day Draft Programme
